Six versus eight weeks of antibiotics for small Mycobacteriumulcerans lesions in Australian Patients.
Antibiotics are highly effective in curing M. ulcerans lesions, but are associated with significant toxicity. In those not undergoing surgery, we compared six weeks with the currently recommended eight weeks combination antibiotic therapy for small M. ulcerans lesions. M. ulcerans cases from an observational cohort at Barwon Health, Victoria, treated with antibiotics alone from 1/10/10-31/3/18 were included. The six-week antibiotic group received ≥ 28 days and ≤ 42 days of antibiotic therapy and the 8-week antibiotic group received ≥ 56 days of antibiotic therapy. Only WHO category 1 lesions were included. 207 patients were included; fifty-three (25.6%) in the six-week group and 154 (74.4%) in the eight-week group. The median age of patients was 53 years (IQR 33-69 years) and 100 (48.3%) were female. Lesions were ≤ 900 mm2 in size in 79.7% of patients and 93.2% of lesions were ulcerative.Fifty-three patients (100%) achieved treatment cure in the six-week group compared with 154 (99.4%) in the eight-week group (p=0.56). No patients died or were lost to follow-up during the study. Median time to heal was 70 days (IQR 60-96 days) in the six-week group compared with 128 days (IQR 95-173 days) in the eight-week group (p<0.001). Two (3.8%) patients in the six-week group experienced a paradoxical reaction compared 39 (25.7%) patients in the eight-week group (p=<0.001). For small M. ulcerans lesions, six weeks may be as effective as the currently recommended eight weeks of combined antibiotic therapy in curing lesions without surgery.